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Abstract
Amino acids signal to the mTOR complex I (mTORC1) growth pathway through the Rag 
GTPases. Multiple distinct complexes regulate the Rags, including GATOR1, a GTPase activating 
protein (GAP), and GATOR2, a positive regulator of unknown molecular function. Arginine 
stimulation of cells activates mTORC1, but how it is sensed is not well understood. Recently, 
SLC38A9 was identified as a putative lysosomal arginine sensor required for arginine to activate 
mTORC1 but how arginine deprivation represses mTORC1 is unknown. Here, we show that 
CASTOR1, a previously uncharacterized protein, interacts with GATOR2 and is required for 
arginine deprivation to inhibit mTORC1. CASTOR1 homodimerizes and can also heterodimerize 
with the related protein, CASTOR2. Arginine disrupts the CASTOR1-GATOR2 complex by 
binding to CASTOR1 with a dissociation constant of ~30 μM, and its arginine-binding capacity is 
required for arginine to activate mTORC1 in cells. Collectively, these results establish CASTOR1 
as an arginine sensor for the mTORC1 pathway.
INTRODUCTION
Arginine is a conditionally essential amino acid with many metabolic and regulatory roles, 
serving as a proteogenic amino acid as well as a precursor for critical molecules such as 
nitric oxide, creatine, and glutamate (Wu and Morris, 1998). Arginine regulates key aspects 
of mammalian physiology, including insulin release, intestinal stem cell migration, and 
neonatal growth (Ban et al., 2004; Floyd et al., 1966; Rhoads et al., 2006; Yao et al., 2008). 
These effects stem at least in part from the ability of arginine to activate mTORC1, a master 
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growth controller that integrates diverse environmental inputs to coordinate many anabolic 
and catabolic processes in cells (Ban et al., 2004; Dibble and Manning, 2013; Efeyan et al., 
2012; Hara, 1998).
The lysosome is a critical organelle for mTORC1 activation, and amino acids promote the 
translocation of mTORC1 to its surface where its kinase activator Rheb, a small GTPase, 
resides (Buerger et al., 2006; Dibble et al., 2012; Menon et al., 2014; Saito et al., 2005; 
Sancak et al., 2008). Necessary for this recruitment are the Rag GTPases, which form 
heterodimeric complexes comprised of RagA or RagB bound to RagC or RagD (Hirose et 
al., 1998; Sancak et al., 2008; Schürmann et al., 1995; Sekiguchi et al., 2001). Amino acid 
availability controls the nucleotide state of the Rags, and this regulation depends on a 
complex interplay between multiple distinct factors, including Ragulator, which serves as a 
lysosomal scaffold for RagA/B (Bar-Peled et al., 2012; Sancak et al., 2010); FLCN/FNIP2, a 
GAP for RagC/D (Petit et al., 2013; Tsun et al., 2013); and GATOR1, a GAP for RagA/B 
and a critical negative regulator of the mTORC1 pathway (Bar-Peled et al., 2013). The 
GATOR2 complex, which has five subunits (mios, WDR24, WDR59, sec13, seh1L), acts 
upstream or parallel to GATOR1 and is a key positive regulator of the mTORC1 pathway, 
although its molecular function is unknown (Bar-Peled et al., 2013).
The proteins that sense amino acids and signal to the Rag GTPases were elusive until 
recently. We identified Sestrin2 as a cytosolic leucine sensor and SLC38A9 as a putative 
lysosomal arginine sensor for the mTORC1 pathway (Rebsamen et al., 2015; Saxton et al., 
2015; Wang et al., 2015; Wolfson et al., 2015). While Sestrin2 interacts with GATOR2 to 
inhibit mTORC1 signaling in the absence of leucine, SLC38A9 forms a supercomplex with 
Ragulator and is necessary for transmitting arginine, but not leucine, sufficiency to 
mTORC1 (Chantranupong et al., 2014; Jung et al., 2015; Lynch et al., 2000; Rebsamen et 
al., 2015; Saxton et al., 2015; Wang et al., 2015; Wolfson et al., 2015; Zoncu et al., 2011). 
Despite these advances, in human cells lacking SLC38A9 arginine starvation still inhibits 
mTORC1 (Wang et al., 2015), suggesting that our understanding of how arginine is sensed 
is incomplete.
Here, we demonstrate that CASTOR1, a previously uncharacterized protein, functions in 
parallel with SLC38A9 to regulate mTORC1 in response to arginine. CASTOR1 forms a 
homodimer and heterodimerizes with CASTOR2, also a previously unstudied protein, and 
both complexes interact with GATOR2 to negatively regulate mTORC1 activity. Arginine, 
but not other amino acids, disrupts this interaction by binding directly to CASTOR1. 
Importantly, activation of the mTORC1 pathway by arginine requires the arginine-binding 
capacity of CASTOR1. Thus, CASTOR1 is an arginine sensor for the mTORC1 pathway.
RESULTS
CASTOR1 and CASTOR2 are ACT domain-containing proteins that interact with GATOR2
Given its central role as a positive regulator of the mTORC1 pathway, GATOR2 is likely to 
integrate multiple amino acid inputs to mTORC1, and therefore other sensors in addition to 
Sestrin2 may interact with it. To identify potential GATOR2-binding partners, we 
interrogated BioPlex, a database of human protein-protein interactions generated from 
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immunoprecipitation followed by mass spectrometry of 2,594 proteins stably expressed in 
HEK-293T cells (Huttlin et al., 2015). In this dataset, three core components of GATOR2 – 
WDR24, WDR59 and mios – were found to interact with the protein encoded by the GATS 
protein-like 3 (GATSL3) gene (Figure 1A). In addition, proteins encoded by the GATSL2 
and FAM164A genes were also present in GATSL3 immunoprecipitates. No prior work 
exists for GATSL3, GATSL2, or FAM164A. For reasons that are described later, we have 
renamed GATSL3 as CASTOR1 (Cellular Arginine Sensor for mTORC1) and GATSL2 as 
CASTOR2.
In humans, CASTOR1 and CASTOR2 reside on chromosome 22 and 7, respectively, and are 
similar, sharing 63% protein sequence identity. Both genes are lowly expressed across most 
tissues, with higher expression in some, such as the muscle for CASTOR2 (Figure S1A). All 
human genome assemblies except the most recent (hg38) annotate on chromosome 7 an 
adjacent duplication of CASTOR2 termed GATSL1. GATSL1 encodes a protein that is nearly 
identical to CASTOR2, having only an N17K change; however, this change is not conserved 
across species nor does it lead to functional differences between GATSL1 and CASTOR2 
(data not shown). Whether or not GATSL1 exists in the human genome is unclear, but if it 
does, GATSL1 is unlikely to encode for a protein that is functionally distinct from 
CASTOR2. Therefore, we do not consider GATSL1 further.
Orthologs of both CASTOR proteins are readily detectable in vertebrates, including 
zebrafish (Figure S1B and C) but are absent in other established model organisms such as 
S. cerevisiae, S. pombe, C. elegans, and D. melanogaster. Database searches also revealed 
the presence of potential CASTOR homologs in invertebrates such as sea urchins and sea 
anemones (Figure S1D). In contrast to vertebrates that encode two CASTOR proteins, these 
organisms encode only one CASTOR-like protein, suggesting that the duplication of an 
ancestral CASTOR gene yielded CASTOR1 and CASTOR2 in vertebrates.
Intriguingly, both CASTOR1 and CASTOR2 contain two tandem ACT domains of 70 - 80 
residues each (Figure 1B). ACTs are evolutionarily ancient domains that function as small 
molecule binding modules for diverse ligands, including amino acids and nucleotides 
(Aravind and Koonin, 1999; Chipman, 2001; Grant, 2006; Lang et al., 2014). These domains 
confer complex allosteric regulation to varied proteins, predominantly bacterial enzymes 
involved in purine and amino acid metabolism. To date, the aromatic amino acid 
hydroxylases are the only ACT-containing proteins identified and characterized in mammals 
(Aravind and Koonin, 1999; Carluccio et al., 2013; Grant, 2006; Kobe et al., 1999; Lang et 
al., 2014; Siltberg-Liberles and Martinez, 2009). A BLAST search of the NCBI protein 
database with each individual CASTOR ACT domain revealed that they are most similar to 
the ACT domains of budding yeast aspartate kinase, which binds lysine (Dumas et al., 
2012), as well as several putative amino acid binding proteins in bacteria (Figure 1C).
We first sought to validate the identification of CASTOR1 as a GATOR2-interacting 
protein. When expressed as an HA-tagged protein in HEK-293T cells, CASTOR1, but not 
the metap2 control protein, co-immunoprecipitated endogenous mios, an established 
GATOR2 component (Figure 1D). Given the sequence similarity of CASTOR1 and 
CASTOR2, we asked whether recombinant CASTOR2 could also interact with GATOR2. 
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Indeed, CASTOR2 co-immunoprecipitated an even greater amount of mios than CASTOR1 
(Figure 1D).
To define which GATOR2 components bind the CASTOR proteins, we compared the ability 
of different GATOR2 subunits to co-immunoprecipitate CASTOR1. Together, WDR24, 
mios, and seh1L form a minimal unit that was sufficient to interact with CASTOR1, 
although it did not recapitulate the degree of binding observed with the complete GATOR2 
complex (Figure S1E). Given that GATOR2 binds not only to the CASTORs but also to 
Sestrin1, Sestrin2, and Sestrin3 (Chantranupong et al., 2014; Kim et al., 2015; Parmigiani et 
al., 2014), we asked whether these proteins occupy unique sites on GATOR2. CASTOR2, 
but not Sestrin2, effectively displaced CASTOR1 from GATOR2, indicating that the 
CASTORs bind to the same site on the GATOR2 complex, and that it is distinct from that 
for the Sestrins (Figure S1F). Collectively, these findings establish CASTOR1 and 
CASTOR2 as ACT domain-containing proteins that interact with GATOR2.
CASTOR1 and CASTOR2 form homo- and heterodimeric complexes
Previous structural studies show that the ACT domains of proteins can oligomerize to form 
multi-protein complexes (Lang et al., 2014). Consistent with this possibility, we noted a 
potential interaction between CASTOR1 and CASTOR2 in BioPlex (Figure 1A). Indeed, 
when overexpressed in cells, CASTOR1 and CASTOR2 robustly interacted with themselves 
and each other to form homo- and heterooligomers (Figure 2A). Gratifyingly, endogenous 
CASTOR2 and CASTOR1 can also participate in heterooligomeric complexes as they 
copurified with recombinant CASTOR1 and CASTOR2, respectively (Figure 2B and C, 
Figure S2A and B). In addition to CASTOR2, we also identified FAM164A, a zinc finger-
containing protein, as a potential interacting partner of CASTOR1 (Figure 1A). However, 
we do not consider FAM164A further as we could not detect an interaction with CASTOR1 
or GATOR2 (Figure S2C and D).
SDS-PAGE followed by Coomassie blue staining showed that purifications of recombinant 
CASTOR1 and CASTOR2 associate in a 1:1 ratio within the heterooligomers (Figure 2D). 
More definitive methods are needed to determine the exact number of proteins in the 
complexes, but for simplicity we refer to them as dimers. Altogether, these data support the 
existence of three CASTOR complexes: the CASTOR1 and CASTOR2 homodimers and the 
CASTOR1-CASTOR2 heterodimer.
Arginine regulates the interaction of the CASTOR1-homodimer and CASTOR1-CASTOR2 
heterodimer with GATOR2
We wondered if the three CASTOR complexes we defined bind differentially to GATOR2. 
Indeed, when overexpressed in HEK-293T cells, the CASTOR2 homodimer interacted more 
strongly with endogenous GATOR2 than the CASTOR1 homodimer, while the CASTOR1-
CASTOR2 heterodimer bound to GATOR2 at an intermediate level (Figure 3A). Because 
endogenous CASTOR2 is present in these cells, it is possible that the GATOR2 interaction 
we observe with the CASTOR1 homodimer is partly due to endogenous CASTOR2 that 
heterodimerizes with overexpressed CASTOR1. However, this is an unlikely possibility 
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because the RNAi-mediated depletion of CASTOR2 did not alter the level of GATOR2 that 
copurified with CASTOR1 (Figure S3A).
Because CASTOR1 and CASTOR2 contain ACT domains that have the potential to bind 
small molecules, we hypothesized that amino acids regulate the CASTOR-GATOR2 
interaction in a manner analogous to how leucine controls the Sestrin2-GATOR2 association 
(Wolfson et al., 2015). Consistent with this prediction, in cells, amino acid withdrawal from 
the culture medium strengthened the interaction of recombinant CASTOR1-containing 
dimers with GATOR2 and re-addition of amino acids rapidly disrupted it (Figure 3A). In 
contrast, amino acids did not affect the interaction between the CASTOR proteins 
themselves whether in homo- or heterodimeric complexes (Figure 3A). Similar to 
recombinant CASTOR1, endogenous CASTOR1 associated in a highly amino acid-sensitive 
manner with endogenous GATOR2 isolated from HEK-293T cells with an antibody directed 
against WDR24, as well as from a HEK-293T cell line expressing endogenously FLAG-
tagged WDR59 (Figure 3B and Figure S3B).
Unlike CASTOR1, amino acids only very weakly regulated the interaction of the CASTOR2 
homodimer with GATOR2 (Figure 3A and B, Figure S3B). We suspected that the slight 
amino acid sensitivity of this complex might stem from the small fraction of CASTOR2 that 
binds to endogenous CASTOR1, thus forming an amino acid-responsive heterodimer. To 
test this possibility, we immunoprecipitated CASTOR2-GATOR2 complexes from cells 
depleted of CASTOR1 by stable coexpression of Cas9 and a guide RNA (sgRNA) targeting 
the CASTOR1 locus. Confirming our suspicions, CASTOR1 depletion eliminated the weak 
amino acid sensitivity of the CASTOR2-GATOR2 interaction (Figure S3C).
Notably, these findings also suggest that the weak interaction we initially detected between 
GATOR2 and CASTOR1 (Figure 1D) resulted from isolating these complexes from cells 
growing in DMEM media, which contains high levels of amino acids that would have 
disrupted most of the CASTOR1-GATOR2 complexes. In contrast, the CASTOR2-
GATOR2 complexes were readily detectable as they are amino acid insensitive.
To determine whether a particular amino acid modulates the interaction of CASTOR1 with 
GATOR2, we focused on leucine and arginine, which have long been known to regulate 
mTORC1 signaling (Ban et al., 2004; Blommaart et al., 1995; Fox et al., 1998; Hara, 1998; 
Lynch et al., 2000). In HEK-293T cells, removal of leucine or arginine from the cell 
medium inhibited mTORC1 signaling to a comparable degree as that of all amino acids, as 
detected by phosphorylated S6K1, an established mTORC1 substrate (Figure 3C). Despite 
similar effects on mTORC1 signaling, only arginine removal recapitulated the ability of total 
amino acid starvation to promote the binding of GATOR2 to CASTOR1-containing 
complexes. Re-stimulation with arginine completely reversed the interaction (Figure 3C and 
Figure S3D). Arginine does not appear to regulate the subcellular distribution of CASTOR1 
in HEK-293T cells, as it was present in both the cytosolic and organellar subcellular 
fractions upon the removal and re-addition of arginine to cells (Figure S3F). CASTOR2 
was in the cytosolic fraction in cells starved for or stimulated with arginine. These results 
are consistent with the notion that both proteins are likely cytosolic, as they lack 
transmembrane domains and obvious localization signals.
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Because CASTOR1 contains ACT domains, we considered the possibility that arginine 
might act directly on CASTOR1 to perturb its interaction with GATOR2. First, we assessed 
whether arginine could disrupt the interaction between CASTOR1 and GATOR2 
immunopurified from amino acid starved cells. Indeed, the addition of 400 μM arginine to 
these purified complexes was sufficient to dissociate GATOR2 from both the CASTOR1 
homodimer and CASTOR1-CASTOR2 heterodimer, with half-maximal disruption occurring 
at an arginine concentration of 20-40 μM (Figure 3D and 3E and Figure S3E). Arginine 
does so with remarkable specificity as none of the other 15 amino acids tested had the same 
effect.
In light of previous structural studies that reveal ligand-induced association of ACT domains 
(Cross et al., 2013; Cross et al., 2011; Lang et al., 2014; Tan et al., 2008), we tested whether 
arginine might mediate its effects on CASTOR1 by regulating the interaction between its 
ACT domains. We divided the CASTOR proteins in half to generate two ACT domain-
containing fragments denoted as ACT1 and ACT2, and performed co-immunoprecipitation 
analyses in arginine-starved and -replete cells. Intriguingly, the CASTOR1 ACT domains 
interact with each other only when arginine is present, with arginine withdrawal from the 
cell medium leading to rapid dissociation of the two CASTOR1 halves. In contrast, the 
CASTOR2 ACT domains bound constitutively to each other, irrespective of arginine 
(Figure 3F). The ability of the CASTOR2 ACT domains to interact without a ligand is at 
odds with the fact that ligand binding induces ACT domain association, and suggests that 
separating the ACT domains may enable them to exhibit novel interactions that are not 
possible in the context of intact CASTOR2. Overall, these data are consistent with the 
notion that differences between the CASTOR1 and CASTOR2 ACT domains underlie the 
ability of arginine to regulate the interaction of GATOR2 with CASTOR1, but not 
CASTOR2. Taken together these data reveal a role for arginine as a regulator of the 
CASTOR1-GATOR2 interaction.
The CASTOR1 homodimer and CASTOR1-CASTOR2 heterodimer bind arginine with a 
dissociation constant of around 30 μM
Because arginine specifically disrupts the purified CASTOR1-GATOR2 complex and 
modulates the interaction between the CASTOR1 ACT domains, we tested the possibility 
that arginine directly binds to CASTOR1. We used an equilibrium binding assay to assess 
whether immunopurified CASTORs from HEK-293T cells bind radiolabelled arginine. 
Indeed, tritiated arginine bound the CASTOR1 homodimer, but not the CASTOR2 
homodimer or a control protein Rap2A, in a manner that was competed by excess 
nonradiolabelled arginine (Figure 4A and B). The CASTOR1-CASTOR2 heterodimer 
bound roughly half as much arginine as the CASTOR1 homodimer, reflecting the fact that 
within this complex only CASTOR1 can bind arginine (Figure 4B). Furthermore, neither 
radiolabelled leucine nor lysine bound to CASTOR1, consistent with the previously 
observed specificity for arginine for disrupting the CASTOR1-GATOR2 complex (Figure 
4A).
It remained a formal possibility that arginine binds to an unidentified protein in the 
mammalian preparations of the CASTOR1 homodimer and CASTOR1-CASTOR2 
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heterodimer. To provide orthogonal evidence that CASTOR1 binds arginine, we purified the 
CASTOR complexes from E. coli, which do not encode a CASTOR homolog. The 
CASTOR1 homodimer and heterodimer, but not Sestrin2, bound arginine to a comparable 
degree as the complexes prepared from human cells, demonstrating that arginine binds 
directly to CASTOR1 and not a co-purifying contaminating protein (Figure 4C).
A competition binding assay with increasing amounts of cold arginine revealed that the Kd 
of arginine for CASTOR1 in the homodimer is 34.8 ± 5.9 μM, which is similar to its Kd in 
the heterodimer of 24.2 ± 4.1 μM (Figure 4D and E). These affinities correlate well with 
the half maximal concentration of arginine that disrupts the interaction of GATOR2 with 
CASTOR1-containing complexes in vitro (Figure 3E) and activates mTORC1 in cells 
(Figure 4F and S4A). In combination, these data strongly support the notion that arginine 
binds directly to CASTOR1 to regulate its interaction with GATOR2.
CASTOR1 functions in parallel with SLC38A9 to regulate arginine sensing by mTORC1
Given the ability of arginine to bind to CASTOR1 and to modulate its interaction with 
GATOR2, we reasoned that CASTOR1 can affect the capacity of the mTORC1 pathway to 
respond to arginine. Indeed, transient overexpression of CASTOR1 driven by the strong 
CMV promoter inhibited mTORC1 activation by amino acids to a similar extent as 
expression of the dominant negative Rag GTPases mutants (Figure 5A).
Conversely, in HEK-293T and HEC59 cells, CASTOR1-depletion mediated by expression 
of either shRNAs or Cas9 with sgRNAs made the mTORC1 pathway substantially 
insensitive to deprivation of arginine (Figure 5B and C, Figure S5B), but not to deprivation 
of leucine or all amino acids (Figure S5D and E). To determine if the RNAi-mediated 
effects are on target, we stably expressed an RNAi-resistant CASTOR1 cDNA in the 
CASTOR1 knockdown cells. To avoid inhibition of the mTORC1 pathway, we used the 
Sestrin2 promoter to express CASTOR1 at levels lower than those obtained with the CMV 
promoter. At this reduced level of expression, reintroduction of CASTOR1 into the 
CASTOR1 knockdown cells restored the arginine responsiveness of the mTORC1 pathway, 
demonstrating that the RNAi effects are on target (Figure S5A). Despite the use of a weaker 
promoter, the level of recombinant CASTOR1 still greatly exceeded that of the endogenous 
protein (Figure S5A). However, this fact does not alter our conclusions because the 
overexpressed CASTOR1 restored, not inhibited, the arginine responsiveness of the 
mTORC1 pathway. Overall, these findings indicate that CASTOR1 is a negative regulator 
of the mTORC1 pathway.
Unlike CASTOR1, CASTOR2 constitutively associates with GATOR2 and does not bind 
arginine, and thus appears to be an arginine-insensitive version of CASTOR1. RNAi-
mediated depletion of CASTOR2 slightly increased mTORC1 activity in the arginine-
replete conditions (Figure 5D), and the knockdown of CASTOR2 together with that of 
CASTOR1 had a similar effect (Figure S5C). CASTOR2 levels are also partially reduced 
by expression of shCASTOR1_2 in HEK-293T cells, which may contribute to the slight 
increase in mTORC1 activation observed with this hairpin under arginine-replete conditions 
(Figure 5B). These results support the notion that CASTOR2, due to its inability to bind to 
Chantranupong et al. Page 7
Cell. Author manuscript; available in PMC 2016 April 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
arginine, dampens mTORC1 activity when arginine is present. However, under arginine 
withdrawal, loss of CASTOR2 does not affect mTORC1 activity because CASTOR1 is still 
present to inhibit the mTORC1 pathway. Further corroborating an inhibitory role for 
CASTOR2, its transient overexpression abrogated mTORC1 activation by amino acids even 
more potently than overexpression of CASTOR1 (Figure 5A). Thus, both CASTOR1 and 
CASTOR2 are negative regulators of arginine signaling to mTORC1.
Consistent with the differential sensitivities of CASTOR1 and CASTOR2 to arginine, mild 
overexpression of each in HEK-293T cells had distinct effects on the response of the 
mTORC1 pathway to arginine. Overexpression of CASTOR2 blunted the maximal level of 
arginine-induced mTORC1 activity, while that of CASTOR1 reduced the sensitivity of the 
pathway to arginine but did not affect its maximal activity (Figure S5F). Like is the case for 
the Sestrins (Budanov et al., 2004; Chen et al., 2010; Lee et al., 2010; Ouyang et al., 2012), 
changes in CASTOR protein levels may be mediated by stress responsive transcription 
factors such as p53 and FOXO1. Consistent with this possibility, analysis of publically 
available ChIP-seq data indicates that FOXO1 binds upstream of and may regulate the 
expression of CASTOR2 in addition to SESN3 (Ouyang et al., 2012).
Finally, we probed the relationship between CASTOR1 and SLC38A9, a putative lysosomal 
arginine sensor that is required to signal the presence of arginine to mTORC1 (Wang et al., 
2015). Consistent with the established role of SLC38A9, arginine-induced activation of 
mTORC1 signaling was severely blunted in HEK-293T cells lacking SLC38A9 (Figure 
5E). RNAi-mediated depletion of CASTOR1 in SLC38A9-null cells renders the mTORC1 
pathway insensitive to arginine: cells neither activated mTORC1 when arginine was present 
nor inactivated mTORC1 when arginine was withdrawn (Figure 5E). While other models 
are possible, it is likely that CASTOR1 and SLC38A9 function in parallel to enable arginine 
to regulate mTORC1, and in their absence, arginine signaling is almost fully defective.
The binding of arginine to CASTOR1 is necessary for it to activate mTORC1
To test whether the activation of mTORC1 by arginine requires the arginine-binding 
capacity of CASTOR1, we used alanine scanning mutagenesis of the CASTOR1 ACT 
domains to identify CASTOR1 mutants that no longer bind arginine. These efforts led to the 
identification of I280A, a mutation within the second ACT domain that fully abrogated the 
ability of CASTOR1 to bind arginine in vitro (Figure 6A).
Consistent with the notion that the binding of arginine to CASTOR1 leads to the disruption 
of the CASTOR1-GATOR2 complex, the arginine-binding mutant of CASTOR1 
constitutively interacted with GATOR2 in cells, irrespective of arginine levels (Figure 6B). 
Notably, this mutant bound more strongly to GATOR2 than its wild type counterpart, 
confirming that arginine modulates the CASTOR1-GATOR2 interaction. In addition, while 
the isolated ACT domains of CASTOR1 associated only in the presence of arginine, an 
I280A change in ACT2 fully abrogated this regulation, and provides further support for an 
important role for this residue in the binding of arginine to CASTOR1 (Figure S6A). 
Further reflecting the importance of this residue in CASTOR1 function, I280 is highly 
conserved in orthologs of CASTOR1 and is present in nearly all bacterial and fungal ACT 
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domains that share sequence homology with the CASTOR1 ACT domain (Figure 1C and 
Figure S1B, C and D).
Finally, if CASTOR1 is a bona fide arginine sensor for the mTORC1 pathway, abolishing its 
ability to bind arginine should in turn abolish the ability of arginine to activate mTORC1 in 
cells. To test this hypothesis, we compared the arginine sensitivity of the mTORC1 pathway 
in CASTOR1 knockdown cells that stably expressed either wild type CASTOR1 or the 
arginine-binding mutant of CASTOR1. Unlike reintroduction of wild type CASTOR1, 
which restores the ability of arginine to signal to mTORC1, expression of the CASTOR1 
arginine-binding mutant rendered the mTORC1 pathway inactive and insensitive to the 
presence of arginine (Figure 6C). In combination, these findings establish that arginine 
must bind to CASTOR1 in order for the mTORC1 pathway to respond to arginine.
DISCUSSION
We establish the CASTOR1 homodimer and CASTOR1-CASTOR2 heterodimer as arginine 
sensors for the mTORC1 pathway. First, arginine binds to both complexes at affinities that 
are consistent with those that activate mTORC1 in cells. Second, CASTOR1 loss leads to 
insensitivity of the mTORC1 pathway to arginine deprivation. Third, expression in cells of 
an arginine-binding mutant of CASTOR1 prevents the mTORC1 pathway from sensing the 
presence of arginine.
The identification of CASTOR1 and Sestrin1 and 2 as sensors for the mTORC1 pathway 
reveal that GATOR2 is a critical hub of amino acid sensing, where leucine and arginine 
signals converge upstream of the Rag GTPases to regulate mTORC1 activity (Figure 6D). 
Leucine and arginine have long been appreciated to be important for mTORC1 activation 
(Ban et al., 2004; Blommaart et al., 1995; Fox et al., 1998; Hara, 1998; Lynch et al., 2000), 
and our findings highlight differences in how these two amino acids are sensed. The 
cytosolic Sestrin proteins are likely the primary leucine sensors because their loss confers 
complete insensitivity of the mTORC1 pathway to leucine deprivation (Saxton et al., 2015; 
Wolfson et al., 2015). In contrast, arginine sensing appears to be more complex and may 
have inputs from two distinct cellular compartments. Loss of function experiments suggests 
that CASTOR1 signals the absence of arginine to inhibit mTORC1. Because CASTOR1 
lacks transmembrane domains and signal sequences it is likely a soluble protein that senses 
free arginine in the cytosol. In contrast, SLC38A9 is needed to signal the presence of 
arginine, presumably lysosomal, to mTORC1. Together, both proteins appear to form 
parallel sensing branches that relay arginine availability to mTORC1. In the absence of both 
CASTOR1 and SLC38A9, arginine no longer regulates the activity of the mTORC1 
pathway.
Despite these insights, several key questions remain. While CASTOR1 and Sestrin2 both 
bind to and likely inhibit GATOR2, whether they operate through distinct mechanisms can 
only be determined once the function of GATOR2 is elucidated. Furthermore, structural 
studies will provide insight into how the binding pocket of CASTOR1 achieves its 
remarkable specificity for arginine. Importantly, these structural studies may also reveal why 
arginine binds to CASTOR1, but not CASTOR2. Although I280 is critical for arginine 
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binding to CASTOR1, this residue is also present in CASTOR2, suggesting that other 
unidentified residues must dictate the difference in arginine binding between these two 
proteins.
In addition, in vivo characterization of mice lacking the CASTOR genes will be needed to 
reveal how arginine sensing varies across tissues and during development. Because arginine 
differentially regulates each CASTOR complex, altering the expression of CASTOR1 versus 
CASTOR2 could serve as a means to modulate mTORC1 activity. CASTOR2 appears 
analogous to Sestrin3, as both are defective in amino acid binding and constitutively 
associate with GATOR2 to inhibit mTORC1 signaling. Thus, increased levels of CASTOR2 
should blunt maximal mTORC1 signaling while those of CASTOR1 may alter the 
sensitivity of the pathway to arginine, as we observed in HEK-293T cells (Figure S5F).
It is likely that additional amino acid sensors exist to signal the presence of other critical 
amino acids for mTORC1 activity, such as glutamine (Jewell et al., 2015), as well sensors 
that mediate the amino acid sensitive events upstream of additional mTORC1 regulators, 
such as Folliculin/FNIP (Petit et al., 2013; Tsun et al., 2013). Characterizing the 
evolutionary conservation of the amino acid sensors of the mTORC1/TORC1 pathway will 
provide insight into how varied are the amino acid inputs that drive mTORC1/TORC1 
signaling in diverse organisms. For instance, budding yeast encodes a homolog of GATOR2, 
but not of the Sestrins or CASTORs, hinting at a divergence in the regulation of the 
upstream components of the nutrient sensing pathway. This divergence may be expected 
given that yeast, unlike mammals, can synthesize all amino acids and thus must sense the 
quality and abundance of nitrogen sources rather than the identity and availability of 
particular amino acids. Further identification and characterization of the amino acid sensors 
upstream of the Rag GTPases will guide us towards a comprehensive understanding of how 
nutrients regulate the mTORC1 pathway.
EXPERIMENTAL PROCEDURES
Materials
Reagents were obtained from the following sources: HRP-labeled anti-mouse and anti-rabbit 
secondary antibodies, lamp and cathepsin antibodies from Santa Cruz Biotechnology; 
antibodies to phospho-T389 S6K1, S6K1, Sestrin2, Histone H3, VDAC and mios from Cell 
Signaling Technology; antibody to the HA epitope from Bethyl laboratories; antibody to 
raptor from Millipore; FLAG M2 antibody, FLAG M2 affinity gel, ATP, and amino acids 
from Sigma Aldrich; HA magnetic beads and RPMI without leucine, arginine, or lysine 
from Pierce; DMEM from SAFC Biosciences; XtremeGene9 and Complete Protease 
Cocktail from Roche; Inactivated Fetal Calf Serum (IFS) from Invitrogen; amino acid-free 
RPMI from US Biologicals; [3H]-labeled amino acids from American Radiolabeled 
Chemicals. The WDR24, Mios, CASTOR1, and CASTOR2 antibodies were generously 
provided by Jianxin Xie (Cell Signaling Technology).
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Cell lines and tissue culture
All cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% 
inactivated fetal calf serum supplemented with 2 mM glutamine. All cell lines were 
maintained at 37°C and 5% CO2.
Preparation of cell lysates and immunoprecipitates
Cell lysate preparation, cell lysis, and immunoprecipitations were performed as described in 
Supplemental Experimental Procedures.
Where indicated, for transient cotransfection experiments, 2 million HEK-293T cells were 
plated in 10 cm dishes and transfected 24 hrs later using the polyethylenimine method 
(Boussif et al., 1995) with the indicated pRK5-based expression vectors: 300 ng HA-
metap2, 40 ng CASTOR1-HA, 80 ng CASTOR1-FLAG, 40 ng CASTOR2-HA, 80 ng 
CASTOR2-FLAG; 100 ng WDR24-FLAG, 100 ng WDR59, 100 ng mios, 150 ng sec13, 
150 ng seh1L, 10 ng or 40 ng or 100 ng or 600 ng of myc-Sestrin2 or myc-CASTOR2; 2 ng 
FLAG-S6K1, 15 ng or 60 ng HA-CASTOR2, 75 ng and 175 ng of CASTOR1-HA. The total 
amount of plasmid DNA in each transfection was normalized to 5 μg with empty pRK5. 
Thirty-six hours after transfection, cells were harvested as described above.
For experiments that required leucine, arginine or amino acid starvation or restimulation, 
cells were treated as previously described (Wolfson et al., 2015). Briefly, cells were 
incubated in leucine, arginine, or amino acid free RPMI for 50 minutes and then 
restimulated with the indicated amino acid(s) for 10 minutes.
Arginine binding assay
Four million HEK-293T cells were plated in a 15 cm plate four days prior to the experiment. 
Forty-eight hours after plating, the cells were transfected via the polyethylenimine method 
(Boussif et al., 1995) with the pRK5-based cDNA expression plasmids indicated in the 
figures in the following amounts: 15 μg FLAG-Rap2A, 400 ng CASTOR1-FLAG or 
CASTOR2-FLAG with 1200 ng CASTOR1-HA or 1200 ng CASTOR2-HA, 400 ng 
CASTOR1 I280A-FLAG with 1200 ng CASTOR1 I280A-HA. The total amount of plasmid 
DNA in each transfection was normalized to 15 μg with empty pRK5. Forty-eight hours 
after transfection cells were lysed and binding assays performed and analyzed as previously 
described (Wolfson et al., 2015).
In vitro CASTOR-GATOR2 dissociation assay
HEK-293T cells cotransfected with 40 ng CASTOR1-HA and either 80 ng CASTOR1-
FLAG (CASTOR1 homodimer) or 80 ng CASTOR2-FLAG (CASTOR1-CASTOR2 
heterodimer) were starved for all amino acids for 50 minutes, lysed and subjected to anti-HA 
immunoprecipitation as described previously. The CASTOR-GATOR2 complexes 
immobilized on agarose beads were washed once in Triton wash buffer, three times in Triton 
wash buffer supplemented with 500 mM NaCl, and then incubated for 20 minutes in 1 mL 
of ice-cold Triton wash buffer supplemented with 500 mM NaCl and the indicated 
concentrations of individual amino acids. The amount of GATOR2 that remained bound to 
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CASTOR complexes was assayed by SDS-PAGE and immunoblotting as previously 
described.
Statistical analysis
Two-tailed t tests were used for comparison between two groups. All comparisons were 
two-sided, and P values of less than 0.001 were considered to indicate statistical 
significance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CASTOR1 and CASTOR2 are ACT domain-containing proteins that interact with 
GATOR2
(A) Endogenous GATOR2, FAM164A, and CASTOR2 co-immunoprecipitate with stably 
expressed CASTOR1. The schematic is adapted from the BioPlex database (Huttlin et al., 
2015). Solid blue lines denote proteins that were detected by mass spectrometric analysis of 
CASTOR1 immunoprecipitates, and dashed purple lines indicate interactions between 
GATOR2 subunits that were present in Bioplex.
(B) Schematic alignment of human CASTOR1 and CASTOR2 proteins with annotated ACT 
domains.
(C) The ACT domains of CASTOR1 and CASTOR2 display sequence similarity with the 
ACT domains of fungal aspartate kinases and putative amino acid binding proteins in 
bacteria. Amino acid positions are colored from white to blue in order of increasing 
sequence identity. The red star denotes the position of the I280 residue in CASTOR1.
(D) Recombinant CASTOR1 and CASTOR2 co-immunoprecipitate endogenous GATOR2, 
as detected by the presence of mios. Anti-HA immunoprecipitates and lysates were prepared 
from HEK-293T cells cotransfected with the indicated cDNAs in expression vectors. Cell 
lysates and immunoprecipitates were analyzed by immunoblotting for levels of indicated 
proteins. HA-metap2 served as a negative control.
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Figure 2. CASTOR1 and CASTOR2 form homo- and heterodimeric complexes
(A) Recombinant CASTOR1 and CASTOR2 coimmunoprecipitate both themselves and 
each other. HEK-293T cells were cotransfected with the indicated cDNAs in expression 
vectors and cell lysates and anti-HA immunoprecipitates were analyzed by immunoblotting 
for the indicated proteins as in Figure 1D.
(B) Recombinant CASTOR2 coimmunoprecipitates endogenous CASTOR1. HEK-293T 
cells were cotransfected with the indicated cDNAs in expression vectors and anti-HA 
immunoprecipitates were collected and analyzed as in Figure 1D. The arrow denotes the 
band corresponding to CASTOR1.
(C) Recombinant CASTOR1 coimmunoprecipitates endogenous CASTOR2. HEK-293T 
cells were cotransfected with the indicated cDNAs in expression vectors and anti-HA 
immunoprecipitates were collected and analyzed as in (A).
(D) Recombinant CASTOR1 and CASTOR2 are present in approximately equal ratios 
within the heterodimeric complex. SDS-polyacrylamide gel electrophoresis (PAGE), 
followed by Coomassie blue staining, was used to analyze the indicated protein preparations 
from HEK-293T cells. The asterisk denotes a common protein contaminant present in these 
purifications.
Chantranupong et al. Page 17
Cell. Author manuscript; available in PMC 2016 April 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Arginine regulates the interaction of GATOR2 with CASTOR1-homodimers and 
CASTOR1-CASTOR2 heterodimers in cells and in vitro
(A) Amino acids differentially regulate the interaction of GATOR2 with the three CASTOR 
complexes. HEK-293T cells cotransfected with the indicated cDNAs were deprived of 
amino acids for 50 min or starved and restimulated with amino acids for 10 min. Anti-HA 
immunoprecipitates and cell lysates were analyzed by immunoblotting for levels of the 
indicated proteins.
(B) Endogenous CASTOR1, but not CASTOR2, associates with GATOR2 in an amino acid-
sensitive manner. A HEK-293T cell line expressing endogenously FLAG-tagged WDR59 
was treated as in (A) and anti-FLAG immunoprecipitates were analyzed by immunoblotting 
for the indicated proteins.
(C) Deprivation of arginine, but not leucine, promotes the interaction between the 
CASTOR1 homodimer and endogenous GATOR2. Cells were deprived of leucine, arginine, 
or all amino acids for 50 min, and restimulated for 10 min with the respective amino acids 
where indicated. Anti-HA immunoprecipitates were prepared and analyzed as in (A).
(D) Arginine disrupts the interaction between GATOR2 and CASTOR1-containing dimers 
in vitro. Anti-HA immunoprecipitates were prepared from HEK-293T cells expressing the 
indicated cDNAs and deprived of amino acids for 50 min. Indicated amino acids were added 
directly to the immunoprecipitates, which after re-washing, were analyzed as in (A).
(E) Arginine dose-dependently disrupts the interaction between GATOR2 and CASTOR1-
containing dimers in vitro. The experiment was performed and analyzed as in (D), except 
using the indicated concentrations of arginine.
(F) Arginine regulates the interaction between the ACT domains of CASTOR1 but not 
CASTOR2 in cells. HEK-293T cells cotransfected with the indicated cDNAs in expression 
vectors were either deprived of arginine in the cell media for 50 min or starved and 
restimulated with arginine for 10 min. Anti-HA immunoprecipitates were prepared and 
analyzed as in (A).
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Figure 4. The CASTOR1 homodimer and CASTOR1-CASTOR2 heterodimer bind arginine with 
a Kd of around 30 μM
(A) Radiolabelled arginine, but not radiolabelled leucine or lysine, binds to CASTOR1 
homodimers. FLAG-immunoprecipitates were prepared from HEK-293T cells cotransfected 
with the indicated cDNAs, and binding assays were performed with these 
immunoprecipitates as described in the methods. Unlabelled amino acids were added where 
indicated. Values are mean ± SD of three technical replicates from one representative 
experiment (n.s., not significant).
(B) Arginine binds to CASTOR1-containing homo- and heterodimers, but not the 
CASTOR2 homodimer. FLAG immunoprecipitates of the indicated complexes were 
prepared from HEK-293T cells and analyzed as in (A). Equal volumes of eluants from 
immunoprecipitates of the denoted complexes were loaded and analyzed in SDS-PAGE, 
followed by Coomassie blue staining.
(C) Arginine binds to bacterially produced CASTOR1-containing complexes, but not the 
CASTOR2 homodimer or the control protein Sestrin2. Proteins purified from bacteria were 
analyzed as in (A) and (B).
(D) Arginine binds to the CASTOR1 homodimer with a dissociation constant of 34.8 μM. 
Binding assays were performed as in (A) with the indicated concentrations of unlabelled 
arginine. A representative experiment is shown, and each point represents the mean ± SD for 
three experiments. The Kd was calculated from four experiments.
(E) Arginine binds to the CASTOR1-CASTOR2 heterodimer with a dissociation constant of 
24.2 μM. FLAG-immunoprecipitates were prepared from HEK-293T cells and analyzed as 
in (D).
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(F) The concentration of arginine that half-maximally activates the mTORC1 pathway 
correlates with the concentration of arginine that disrupts half of the complexes of GATOR2 
and CASTOR1 homodimers. HEK-293T cells were transfected with the indicated cDNAs 
and immunoprecipitates and lysates analyzed as in Figure 3C.
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Figure 5. CASTOR1 functions in parallel with SLC38A9 to regulate arginine signaling to 
mTORC1
(A) Transient overexpression of recombinant CASTOR2 and CASTOR1 inhibits mTORC1 
activation in response to amino acids. HEK-293T cells were cotransfected with the indicated 
cDNAs. Cells were treated as in Figure 3A and anti-FLAG immunoprecipitates analyzed by 
immunoblotting for the indicated proteins.
(B) RNAi-mediated depletion of CASTOR1 in HEK-293T cells renders the mTORC1 
pathway partially insensitive to arginine deprivation. HEK-293T cells stably expressing the 
indicated shRNAs were starved of arginine in the cell media for 50 min or starved and 
restimulated with arginine for 10 min. Lysates were analyzed via immunoblotting for the 
indicated proteins and phosphorylation states.
(C) CRISPR/Cas9 mediated depletion of CASTOR1 in HEK-293T cells confers resistance 
of the mTORC1 pathway to arginine deprivation. HEK-293T cells stably coexpressing Cas9 
with the indicated guide RNAs were treated as in (B) and lysates were analyzed by 
immunoblotting for indicated proteins.
(D) Loss of CASTOR2 slightly increases mTORC1 activity in response to arginine. 
HEK-293T cells stably expressing the indicated shRNAs were treated as in (B) and lysates 
were analyzed by immunoblotting for indicated proteins. The normalized phosphorylated 
S6K1 signal under arginine stimulation for shCASTOR2_1 and shCASTOR2_2 expressing 
cells is 1.4 fold and 1.1 fold of shGFP expressing cells, respectively, as quantified with 
ImageJ.
(E) CASTOR1 and SLC38A9 likely function in parallel to signal arginine availability to the 
mTORC1 pathway. Wild type or SLC38A9 knockout HEK-293T cells expressing the 
indicated shRNAs were treated as in (B) and lysates were analyzed by immunoblotting for 
indicated proteins.
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Figure 6. Arginine must be able to bind to CASTOR1 for it to activate mTORC1
(A) The CASTOR1 I280A mutant does not bind arginine. Binding assays were performed 
with FLAG immunoprecipitates of the indicated complexes as in Figure 4A.
(B) Arginine does not regulate the interaction of CASTOR1 I280A with GATOR2. 
HEK-293T cells cotransfected with the indicated cDNAs in expression vectors were treated 
as in Figure 5B and anti-HA immunoprecipitates were analyzed by immunoblotting for 
levels of the indicated proteins.
(C) Reintroduction of the CASTOR1 I280A mutant into CASTOR1 knockdown cells 
renders the mTORC1 pathway unable to sense the presence of arginine. HEK-293T cells 
stably expressing the indicated shRNAs and cDNA constructs were treated as in Figure 5B 
and lysates analyzed by immunoblotting for indicated proteins.
(D) A model depicting how the cytosolic and lysosomal amino acid inputs impinge on 
CASTORs, Sestrins, and SLC38A9 to regulate mTORC1 activity.
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